Capnia’s CoSense® ETCO Monitor to be Showcased at the 2016 Mobile World Congress
Feb 22, 2016 21:05 pm UTC| Business
REDWOOD CITY, Calif., Feb. 22, 2016 -- Capnia, Inc. (NASDAQ:CAPN), a diversified healthcare company that develops and commercializes innovative diagnostics, devices and therapeutics addressing unmet medical needs, today...
Authentidate Announces Second Quarter Financial Results
Feb 22, 2016 21:05 pm UTC| Business
BERKELEY HEIGHTS, N.J., Feb. 22, 2016 -- Authentidate Holding Corp. (OTCQB:ADAT), a provider of secure web-based revenue cycle management applications and telehealth products and services for healthcare organizations,...
NanoString Technologies to Present at the Cowen and Company 36th Annual Health Care Conference
Feb 22, 2016 21:05 pm UTC| Business
SEATTLE, Feb. 22, 2016 -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced that the company’s management is...
Feb 22, 2016 21:05 pm UTC| Business
EVANSTON, Ill., Feb. 22, 2016 -- Fidus Investment Corporation (NASDAQ:FDUS) (“Fidus” or the “Company”) today announced that it will report its fourth quarter and full year 2015 financial results on Thursday, March 3,...
Stereotaxis Reports 2015 Fourth Quarter and Full Year Financial Results
Feb 22, 2016 21:05 pm UTC| Business
New capital orders of $5.1 million in the fourth quarter, including two Niobe® ES system orders in JapanFourth quarter free cash flow of $1.6 million, driving a 71% reduction in full year cash burn compared to...
Greenlight Re Announces Fourth Quarter and Year End 2015 Financial Results
Feb 22, 2016 21:05 pm UTC| Business
GRAND CAYMAN, Cayman Islands, Feb. 22, 2016 -- Greenlight Capital Re, Ltd. (NASDAQ:GLRE) today announced financial results for the fourth quarter and year ended December 31, 2015. Greenlight Re reported a net loss of...
Feb 22, 2016 21:05 pm UTC| Business
GAITHERSBURG, Md., Feb. 22, 2016 -- Novavax, Inc. (Nasdaq:NVAX), a clinical-stage vaccine company focused on the discovery, development and commercialization of recombinant nanoparticle vaccines and adjuvants, today...